Home › Agent Hub › Agent Tools › Part D coverage by drug › Eszopiclone
Agent Tools
Eszopiclone is a generic drug. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 3,051 of 5,492 Medicare Part D and Medicare Advantage drug plans (55.6%) list Eszopiclone on their formulary, across 215 of 286 formularies. The most common placement is tier 4 (1,467 plans, 48.1% of those covering it). 110 of the covering plans require prior authorization (3.6%), 0 step therapy and 2,925 a quantity limit.
537 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $0, 277 of them $0; 2,514 charge coinsurance instead — median 25% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 2,954 of 5,496 plans covered it (53.7%); 2027: 3,051 of 5,492 (55.6%).
Of 4,367 plans offered in both years, 207 added it to the formulary and 70 dropped it.
Among plans covering it both years, 96 moved it to a higher tier and 25 to a lower one; 8 added prior authorization and 33 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 216 |
| Tier 2 | 368 |
| Tier 3 | 1,000 |
| Tier 4 | 1,467 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 116 of 323 | 35.9% | 0% |
| Medicare Advantage with drugs (MA-PD) | 1,758 of 3,200 | 54.9% | 1.9% |
| Special needs plans (SNP) | 1,177 of 1,969 | 59.8% | 6.5% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 846 of 846 | Tier 4 | 0 |
| UnitedHealthcare | 757 of 830 | Tier 3 | 0 |
| Devoted Health | 0 of 728 | No tier listed | 0 |
| Aetna Medicare | 0 of 631 | No tier listed | 0 |
| Wellcare | 0 of 268 | No tier listed | 0 |
| HealthSpring | 0 of 226 | No tier listed | 0 |
| Kaiser Permanente | 112 of 112 | Tier 2 | 0 |
| SCAN Health Plan | 0 of 83 | No tier listed | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 0 of 80 | No tier listed | 0 |
| Alignment Health Plan | 77 of 77 | Tier 2 | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 4 | 0 |
| Wellpoint | 63 of 63 | Tier 4 | 0 |
| Priority Health Medicare | 40 of 40 | Tier 4 | 0 |
| CarePlus Health Plans, Inc. | 37 of 37 | Tier 4 | 0 |
| Zing Health | 0 of 36 | No tier listed | 0 |
| Capital Blue Cross | 35 of 35 | Tier 3 | 0 |
| Prominence Health Plan | 29 of 29 | Tier 4 | 0 |
| Medica | 1 of 27 | Tier 4 | 0 |
| Anthem HealthKeepers | 26 of 26 | Tier 4 | 0 |
| Blue Cross Blue Shield of Michigan | 0 of 26 | No tier listed | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 43 of 114 | 37.7% |
| Alaska | 3 of 9 | 33.3% |
| American Samoa | 0 of 1 | 0% |
| Arizona | 82 of 147 | 55.8% |
| Arkansas | 38 of 85 | 44.7% |
| California | 281 of 397 | 70.8% |
| Colorado | 63 of 106 | 59.4% |
| Connecticut | 20 of 54 | 37% |
| Delaware | 16 of 43 | 37.2% |
| District of Columbia | 9 of 12 | 75% |
| Florida | 337 of 545 | 61.8% |
| Georgia | 73 of 149 | 49% |
| Guam | 0 of 1 | 0% |
| Hawaii | 22 of 50 | 44% |
| Idaho | 31 of 45 | 68.9% |
| Illinois | 61 of 132 | 46.2% |
| Indiana | 85 of 138 | 61.6% |
| Iowa | 36 of 64 | 56.3% |
| Kansas | 42 of 84 | 50% |
| Kentucky | 83 of 121 | 68.6% |
| Louisiana | 75 of 125 | 60% |
| Maine | 30 of 52 | 57.7% |
| Maryland | 26 of 49 | 53.1% |
| Massachusetts | 61 of 89 | 68.5% |
| Michigan | 93 of 182 | 51.1% |
| Minnesota | 38 of 63 | 60.3% |
| Mississippi | 46 of 104 | 44.2% |
| Missouri | 84 of 170 | 49.4% |
| Montana | 20 of 27 | 74.1% |
| Nebraska | 26 of 51 | 51% |
| Nevada | 73 of 100 | 73% |
| New Hampshire | 14 of 25 | 56% |
| New Jersey | 41 of 73 | 56.2% |
| New Mexico | 49 of 68 | 72.1% |
| New York | 108 of 215 | 50.2% |
| North Carolina | 96 of 176 | 54.5% |
| North Dakota | 12 of 26 | 46.2% |
| Northern Mariana Islands | 0 of 1 | 0% |
| Ohio | 85 of 171 | 49.7% |
| Oklahoma | 53 of 81 | 65.4% |
| Oregon | 49 of 92 | 53.3% |
| Pennsylvania | 155 of 323 | 48% |
| Puerto Rico | 1 of 64 | 1.6% |
| Rhode Island | 19 of 29 | 65.5% |
| South Carolina | 46 of 89 | 51.7% |
| South Dakota | 10 of 30 | 33.3% |
| Tennessee | 58 of 156 | 37.2% |
| Texas | 237 of 407 | 58.2% |
| U.S. Virgin Islands | 0 of 1 | 0% |
| Utah | 35 of 53 | 66% |
| Vermont | 7 of 14 | 50% |
| Virginia | 104 of 144 | 72.2% |
| Washington | 73 of 114 | 64% |
| West Virginia | 42 of 69 | 60.9% |
| Wisconsin | 76 of 96 | 79.2% |
| Wyoming | 6 of 13 | 46.2% |
Medicare Part D paid for 1,062,884 30-day fills of Eszopiclone in 2024 for about 186,407 enrollees, at an average total cost of $16.54 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Eszopiclone and the rest of a client's list on every plan in their county.
Estimate Eszopiclone costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.